Nova Eye Medical Stock Net Income
| ELXMF Stock | USD 0 0.00 0.00% |
As of the 10th of February, Nova Eye secures the Mean Deviation of 2.93, standard deviation of 12.08, and Risk Adjusted Performance of (0.09). Nova Eye Medical technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices. Please verify Nova Eye Medical risk adjusted performance, standard deviation, as well as the relationship between the Standard Deviation and maximum drawdown to decide if Nova Eye Medical is priced some-what accurately, providing market reflects its recent price of 0.0019 per share. As Nova Eye Medical appears to be a penny stock we also strongly suggest to check its information ratio numbers.
Nova Eye's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Nova Eye's valuation are provided below:Nova Eye Medical does not presently have any fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Nova |
Nova Eye 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Nova Eye's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Nova Eye.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in Nova Eye on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding Nova Eye Medical or generate 0.0% return on investment in Nova Eye over 90 days. Nova Eye is related to or competes with PetVivo Holdings, Novacyt SA, Positron Corp, and Perimeter Medical. Nova Eye Medical Limited designs, develops, distributes, markets, sells, and services surgical devices for the treatment... More
Nova Eye Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Nova Eye's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Nova Eye Medical upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 98.1 |
Nova Eye Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nova Eye's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Nova Eye's standard deviation. In reality, there are many statistical measures that can use Nova Eye historical prices to predict the future Nova Eye's volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (1.62) | |||
| Total Risk Alpha | (2.83) | |||
| Treynor Ratio | (1.06) |
Nova Eye February 10, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.09) | |||
| Market Risk Adjusted Performance | (1.05) | |||
| Mean Deviation | 2.93 | |||
| Coefficient Of Variation | (812.40) | |||
| Standard Deviation | 12.08 | |||
| Variance | 145.81 | |||
| Information Ratio | (0.13) | |||
| Jensen Alpha | (1.62) | |||
| Total Risk Alpha | (2.83) | |||
| Treynor Ratio | (1.06) | |||
| Maximum Drawdown | 98.1 | |||
| Skewness | (8.12) | |||
| Kurtosis | 66.0 |
Nova Eye Medical Backtested Returns
Nova Eye Medical has Sharpe Ratio of -0.13, which conveys that the firm had a -0.13 % return per unit of risk over the last 3 months. Nova Eye exposes sixteen different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Nova Eye's Risk Adjusted Performance of (0.09), mean deviation of 2.93, and Standard Deviation of 12.08 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 1.42, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Nova Eye will likely underperform. At this point, Nova Eye Medical has a negative expected return of -1.56%. Please make sure to verify Nova Eye's standard deviation, as well as the relationship between the maximum drawdown and day median price , to decide if Nova Eye Medical performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.00 |
No correlation between past and present
Nova Eye Medical has no correlation between past and present. Overlapping area represents the amount of predictability between Nova Eye time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Nova Eye Medical price movement. The serial correlation of 0.0 indicates that just 0.0% of current Nova Eye price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | -0.07 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Nova Eye Medical reported net income of (7.5 Million). This is 102.2% lower than that of the Healthcare sector and 103.15% lower than that of the Medical Devices industry. The net income for all United States stocks is 101.31% higher than that of the company.
Nova Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nova Eye's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Nova Eye could also be used in its relative valuation, which is a method of valuing Nova Eye by comparing valuation metrics of similar companies.Nova Eye is currently under evaluation in net income category among its peers.
Nova Fundamentals
| Return On Equity | -0.23 | |||
| Return On Asset | -0.15 | |||
| Profit Margin | (0.56) % | |||
| Operating Margin | (0.72) % | |||
| Current Valuation | 25.06 M | |||
| Shares Outstanding | 145.88 M | |||
| Shares Owned By Insiders | 21.26 % | |||
| Shares Owned By Institutions | 18.91 % | |||
| Price To Earning | 0.66 X | |||
| Price To Book | 0.92 X | |||
| Price To Sales | 2.18 X | |||
| Revenue | 13.63 M | |||
| Gross Profit | 11.09 M | |||
| EBITDA | (7.89 M) | |||
| Net Income | (7.5 M) | |||
| Cash And Equivalents | 8 M | |||
| Cash Per Share | 0.05 X | |||
| Total Debt | 1.94 M | |||
| Debt To Equity | 0.06 % | |||
| Current Ratio | 4.03 X | |||
| Book Value Per Share | 0.21 X | |||
| Cash Flow From Operations | (4.72 M) | |||
| Earnings Per Share | (0.02) X | |||
| Target Price | 1.0 | |||
| Number Of Employees | 20 | |||
| Beta | 0.86 | |||
| Market Capitalization | 26.82 M | |||
| Total Asset | 36.62 M | |||
| Z Score | 7.8 | |||
| Net Asset | 36.62 M |
About Nova Eye Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nova Eye Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nova Eye using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nova Eye Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Nova Pink Sheet
Nova Eye financial ratios help investors to determine whether Nova Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nova with respect to the benefits of owning Nova Eye security.